Patents by Inventor Mathieu Coureuil

Mathieu Coureuil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS
    Publication number: 20190211066
    Abstract: The present invention stems from the finding that the interaction between the ?2 adrenoceptor (?2AP) and type IV pilus-associated proteins initiates a process leading to the opening of the blood-brain barrier The invention therefore pertains to a vaccine for preventing the spreading of meningococci into the meningcal space, wherein said vaccine allows the production of antibodies inhibiting the interaction between the type IV pilus-associated proteins and the ?2AP.
    Type: Application
    Filed: March 21, 2019
    Publication date: July 11, 2019
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M EDICALE (INSERM), UNIVERSITE PARIS DESCARTES
    Inventors: Mathieu COUREUIL, Xavier NASSIF, Stefano MARULLO
  • VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS
    Publication number: 20180037612
    Abstract: The present invention stems from the finding that the interaction between the ?2 adrenoceptor (?2AP) and type IV pilus-associated proteins initiates a process leading to the opening of the blood brain barrier. The invention therefore pertains to a vaccine for preventing the spreading of meningococci into the meningeal space, wherein said vaccine allows the production of antibodies inhibiting the interaction between the type IV pilus-associated proteins and the ?2AP.
    Type: Application
    Filed: September 13, 2017
    Publication date: February 8, 2018
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PARIS DESCARTES
    Inventors: Mathieu COUREUIL, Xavier NASSIF, Stefano MARULLO
  • VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS
    Publication number: 20160185827
    Abstract: The present invention stems from the finding that the interaction between the ?2 adrenoceptor (?2AP) and type IV pilus-associated proteins initiates a process leading to the opening of the blood-brain barrier. The invention therefore pertains to a vaccine for preventing the spreading of meningococci into the meningeal space, wherein said vaccine allows the production of antibodies inhibiting the interaction between the type IV pilus-associated proteins and the ?2AP.
    Type: Application
    Filed: March 9, 2016
    Publication date: June 30, 2016
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PARIS DESCARTES
    Inventors: Mathieu COUREUIL, Xavier NASSIF, Stefano MARULLO
  • VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS
    Publication number: 20130287808
    Abstract: The present invention stems from the finding that the interaction between the ?2 adrenoceptor (?2AP) and type IV pilus-associated proteins initiates a process leading to the opening of the blood-brain barrier. The invention therefore pertains to a vaccine for preventing the spreading of meningococci into the meningeal space, wherein said vaccine allows the production of antibodies inhibiting the interaction between the type IV pilus-associated proteins and the ?2AP.
    Type: Application
    Filed: November 4, 2011
    Publication date: October 31, 2013
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PARIS DESCARTES
    Inventors: Mathieu Coureuil, Xavier Nassif, Stefano Marullo